Aarey Drugs & Pharmaceuticals Ltd share price logo

Aarey Drugs Share Price

NSE: AAREYDRUGS

BSE: 524412

Small Cap

Healthcare Sector

₹65.91

-3.46

(-4.99%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Aarey Drugs Stock Performance

as on January 12, 2026 at 4:01 pm IST

  • Day's High

    ₹65.91
    ₹70.28

    6.63%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹31.35
    ₹100
    downward going graph

    52.44%

    Downside

    51.72%

    Upside

    downward going graph

Aarey Drugs share price movements today

Previous Close
₹69.37
Open
₹70.28
Volume
49.72K
Upper Circuit
₹72.83
Lower Circuit
₹65.91
Day's Low - High
₹65.91 - ₹70.28
52 Week Low - High
₹31.35 - ₹100

Aarey Drugs Historical Returns

1 Month Return
+ 3.28 %
3 Month Return
-16.92 %
1 Year Return
+ 30.39 %
3 Year Return
+ 84.01 %
5 Year Return
+ 60.02 %

Aarey Drugs Fundamentals

as on January 12, 2026 at 4:01 pm IST

Market Cap

₹196.69 Cr

Return on Equity (ROE)

2.96

PE Ratio (TTM)

0

Return on capital employed (ROCE)

6.38

Beta (LTM)

0.99

P/B Ratio

0.72

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-36.25

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bearish

View Technical Analysis

Aarey Drugs & Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aarey Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Aarey Drugs & Pharmaceuticals Ltd image
Aarey Drugs & Pharmaceuticals Ltd
NA196.6912%0.004473
Krebs Biochemicals & Industries Ltd image
Krebs Biochemicals & Industries Ltd
NA144.26-9.85%0.00-2743
Haleos Labs Limited image
Haleos Labs Limited
NA391.0624.02%0.6818344
Vivanza Biosciences Ltd image
Vivanza Biosciences Ltd
NA9.08-16.42%0.84-17
Kimia Biosciences Ltd image
Kimia Biosciences Ltd
NA152.58-7.89%0.009118
See all

Aarey Drugs Share Price Target

Get share price movements and forecasts by analysts on Aarey Drugs.

Source: S&P Global Market Intelligence

Aarey Drugs & Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
162.88
50.96
57.83
76.48
210.35
126.91
105.14
133.79
108.1
102.21
84.16
Other Income
0.84
0.7
0.84
0.29
5.14
1.58
0.02
0.68
7.54
1.55
0.79
Total Income
163.72
51.65
58.67
76.77
215.49
128.49
105.16
134.47
115.64
103.76
84.95
Expenses
160.36
49.62
55.98
73.77
211.79
125.73
101.42
131.59
112.3
100.51
81.52
Operating Profit
2.52
1.34
1.85
2.71
-1.44
1.18
3.72
2.2
-4.2
1.7
2.64
Operating Profit Margin %
1.55%
2.63%
3.2%
3.54%
-0.68%
0.93%
3.54%
1.64%
-3.89%
1.66%
3.14%
Profit Before Interest, Tax and Depreciation
3.36
2.04
2.68
3
3.7
2.75
3.74
2.88
3.33
3.25
3.44
Interest
0.2
0.42
0.41
0.47
0.4
0.96
0.49
0.58
1.3
1.04
1.26
Depreciation
1.02
0.89
1.27
1.06
1.15
0.47
1.51
0.9
0.41
0.49
0.69
Profit Before Tax
2.14
0.73
1
1.47
2.15
1.32
1.74
1.4
1.62
1.72
1.49
Tax Paid
1.78
-
-0.22
0.44
-0.01
0.09
0.15
0.68
1.16
0.36
0.46
Profit After Tax
0.36
0.72
1.23
1.02
2.15
1.24
1.6
0.72
0.47
1.37
1.02
Total Net profit including share of profit / Loss from associate company
0.36
0.72
1.23
1.02
2.15
1.24
1.6
0.72
0.47
1.37
1.02
EPS
0.14
0.29
0.48
0.4
0.77
0.44
0.57
0.26
0.17
0.48
0.36
Actual EPS
0.14
0.29
0.48
0.4
0.77
0.44
0.57
0.26
0.17
0.48
0.36
Adjusted EPS
0.14
0.29
0.48
0.4
0.77
0.44
0.57
0.26
0.17
0.48
0.36
Diluted EPS
0.14
0.29
0.48
0.4
0.77
0.44
0.57
0.26
0.17
0.48
0.36

Aarey Drugs & Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
395.97
349.35
354.74
300.09
348.42
492.68
418.96
395.62
473.94
Other Income
3.34
3.18
4.34
6.69
7.01
2.75
2.73
6.96
9.81
Total Income
399.3
352.53
359.08
306.78
355.43
495.43
421.69
402.58
483.76
Expenses
386.44
341.75
346.86
296.89
343.78
481.41
411.23
391.17
471.04
Operating Profit
9.53
7.6
7.88
3.2
4.64
11.27
7.73
4.45
2.9
Operating Profit Margin %
2.41%
2.18%
2.22%
1.07%
1.33%
2.29%
1.85%
1.12%
0.61%
Profit Before Interest, Tax and Depreciation
12.87
10.78
12.22
9.89
11.65
14.02
10.46
11.42
12.71
Interest
4.25
1.88
2.23
1.76
2.43
2
1.57
1.7
4.66
Depreciation
0.64
0.71
1.01
0.89
0.92
1.99
2.87
4.38
1.94
Profit Before Tax
7.98
8.19
8.98
7.24
8.3
10.03
6.02
5.34
6.11
Tax Paid
2.51
2.01
2.44
1.45
1.78
3.48
2.24
0.66
2.08
Profit After Tax
5.47
6.18
6.54
5.79
6.51
6.54
3.78
4.68
4.02
Total Net profit including share of profit / Loss from associate company
5.47
6.18
6.54
5.79
6.51
6.54
3.78
4.68
4.02
EPS
3.03
2.64
2.8
2.48
2.79
2.72
1.49
1.84
1.43
Actual EPS
3.03
2.64
2.8
2.48
2.79
2.72
1.49
1.84
1.43
Adjusted EPS
3.03
2.64
2.8
2.48
2.79
2.72
1.49
1.84
1.43
Diluted EPS
3.03
2.64
2.8
2.48
2.79
2.72
1.49
1.84
1.84

Aarey Drugs & Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
5.66
0.62
-20.35
0.69
2.86
5.48
0.5
-1.28
-2.99
10.3
Cash Flow from Investing Activities
-2.58
-4.97
-0.6
-1.23
-0.92
-2.88
-3.21
0.45
-1.7
-5.94
Cash Flow from Financing Activities
-1.63
3.74
23.3
-2.48
-1.81
-2.45
2.25
1.35
5.57
-4.48
Net Cash Flow
1.45
-0.58
2.35
-3.02
0.13
0.15
-0.46
0.51
0.89
-0.12

Aarey Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Aarey Drugs.

  • Aarey Drugs & Pharmaceuticals Ltd Earnings Results

    Aarey Drugs & Pharmaceuticals Ltd’s net profit fell -36.25% since last year same period to ₹1.02Cr in the Q2 2025-2026. On a quarterly growth basis, Aarey Drugs & Pharmaceuticals Ltd has generated -25.55% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Aarey Drugs & Pharmaceuticals Ltd Dividends November,2018

    In the quarter ending September 2018, Aarey Drugs & Pharmaceuticals Ltd has declared dividend of ₹0.10 per share on 30 Nov 2018 - translating a dividend yield of 0.14%.

    Read More about Dividends

Insights on Aarey Drugs & Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AAREYDRUGS stock has moved up by 2.6%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, AAREYDRUGS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 53.23% to 54.07% in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 156.3% return, outperforming this stock by 72.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.80% of holdings in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.97% to 1.13% in Sep 2025 quarter

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs Pharmaceuticals Ltd is one of the India's leading manufacturers and suppliers of pharmaceutical raw materials, chemicals, pharmaceuticals ingredients, APIs, drugs, food colours and flavours. The company is equipped with a manufacturing unit located in Thane and has its corporate office in Mumbai. It was established in 1990 and is governed by central and state legislations that regulate the business. Their products meet the IP/ BP/ CP/ USP standards and are sourced from authentic vendors to guarantee quality and effectiveness. The company floated a public issue in 1993 of 27.5 lakh equity shares of Rs. 10 each and was listed on 3 stock exchanges. In 2009, the plant was upgraded to international standards. They also plan to manufacture new products and expand the existing production capacity of Metronidazole MTZ from 420 MT to 780 MT and Metronidazole Benzoate MBO from 120 MT to 240 MT. Aarey Drugs and Pharmaceuticals Ltd is a trusted manufacturer of pharmaceutical products and has been providing quality products since its establishment.

Revenue: ₹84.16Cr as on September 2025 (Q2 FY26)
Net Profit: ₹1.02Cr as on September 2025 (Q2 FY26)
Listing date: 06 Aug, 2021
Chairperson Name: Mihir R Ghatalia
OrganisationAarey Drugs & Pharmaceuticals Ltd
IndustryPharmaceuticals
CEOMihir R Ghatalia
E-voting on sharesClick here to vote

FAQs

What is Aarey Drugs share price today?

Aarey Drugs share price today stands at ₹65.91 as on at the close of the market. Aarey Drugs share today touched a day high of ₹70.28 and a low of ₹65.91.

What is the 52 week high and 52 week low range for Aarey Drugs share?

Aarey Drugs touched a 52 week high of ₹100 and a 52 week low of ₹31.35. Aarey Drugs share price today i.e. is closed at ₹65.91, which is -34.09% down from its 52 week high and 110.24% up from its 52 week low.

What is Aarey Drugs's market capitalisation today?

Aarey Drugs market capitalisation is ₹196.69 Cr as on .

How to buy Aarey Drugs shares?

To buy Aarey Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AAREYDRUGS or Aarey Drugs & Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Aarey Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Aarey Drugs trading volume today?

Aarey Drugs trading volume is 49.72K as on . This means that 49.72K shares of Aarey Drugs were bought and sold on the stock market during today's trading session.